Physician profile
Ira Morris Goldstein
NPI 1427088590
$343,705.78
in general payments reported to CMS, 2019-2025
15 companies · $68K in 2025
The $68K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $30K · 2021: $40K · 2022: $49K · 2023: $60K · 2024: $51K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $174K · Travel and Lodging: $3,331 · Food and Beverage: $2,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $174,052.77 |
| Travel and Lodging | $3,330.80 |
| Food and Beverage | $2,490.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $265,882.42 | 2019-2025 | Hedron, Hedron C, Hedron Ic |
| Alphatec Spine, INC | $42,178.88 | 2019-2025 | Other - Miscellaneous, Solanas |
| Zimmer Biomet Holdings, INC. | $28,482.72 | 2019-2020 | |
| Stryker Corporation | $2,121.25 | 2019-2023 | Bio4 |
| Baxter Healthcare | $1,552.80 | 2019-2023 | Actifuse |
| Nuvasive, INC. | $1,480.67 | 2021-2023 | Acp, Xlif, Tlx |
| Vb Spine LLC | $1,118.60 | 2025 | Mesa Spinal System, Xia 3, Lite Bio Delivery System |
| Cerapedics INC. | $228.25 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Augmedics INC. | $201.25 | 2024 | Xvision |
| Bioventus LLC | $156.50 | 2019 | |
| Next Science LLC | $134.76 | 2023 | Xperience, Blastx, Surgx |
| Icotec Medical INC. | $125.00 | 2022 | |
| Ethicon US, LLC | $26.40 | 2019 | |
| Zimvie INC. | $16.28 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.